We break down the biggest gainers and droppers in the Cheddar 50 index this year, plus one Japanese stock that's made a big splash in the U.S. in 2017.
On the plus side, shares of Square have risen about 160 percent this year as the digital payment company has expanded into new markets. And video game maker Take-Two Interactive has also more than doubled in 2017, as investors and fans both await the release of Red Dead Redemption 2 this spring.
But they weren't all winners. Pandora shares were down more than 60 percent as the music streaming service struggled to grow paying subscribers. And Blue Apron stock has dropped as much as 70 percent since its IPO in late June, losing its CEO and cutting jobs.
Plus, what about Japan's SoftBank? The tech holding company launched its $100 billion Vision Fund, which has made investments in Nvidia, WeWork and Flipkart. And we're still waiting for what could be a $10 billion investment in Uber.
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
Mario Veneroso, Kingsview Asset Management Partner, weighs in on the latest economic data and whether the market is pricing in too many rate cuts for the coming year.
